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Background: Several micro-environmental and cell-intrinsic stimuli cause tumor cells to 
undergo endoplasmic reticulum (ER) stress in vivo. The occurrence of an ER stress response 
has been associated with tumor progression and angiogenesis. Recently, we found that pharma-
cological induction of ER stress in B lymphoma cells upregulates the transcription of several 
pro-inflammatory cytokines.
Results: Here, we show that transgenic adenocarcinoma of the mouse prostate (TRAMP) C1 
murine prostate cancer cells induced to undergo ER stress in vitro activate the transcription of 
interleukin 6 (IL-6), interleukin 23p19 (IL-23p19), and tumor necrosis factor α (TNF-α). Further-
more we show that TRAMP C1 tumors growing in vivo spontaneously experience ER stress and 
that transcription of IL-6, IL-23p19, and TNF-α correlates with the in vivo ER stress response.
Conclusions: These results suggest that an ER stress response in prostate cancer cells activates 
a program of pro-inflammatory cytokine transcription. A possible implication of this finding is 
that cancer cells may use the ER stress response to modify their microenvironment.
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Background
The endoplasmic reticulum (ER) is the initial checkpoint for the biosynthesis, folding, 
assembly, and modification of membrane-bound and secreted proteins in all eukaryotic 
cells. Stimuli that cause the accumulation of un/misfolded proteins in the ER lumen 
result in a condition known as ER stress.1 Eukaryotic cells have evolved a set of 
intracellular signaling pathways known collectively as the unfolded protein response 
(UPR) that facilitates cellular adaptation to ER stress. In mammalian cells, the UPR is 
initiated by three ER membrane-bound sensors (inositol-requiring protein 1α (Ire1α), 
Activating transcription factor 6 (Atf6), protein kinase-like endoplasmic reticulum 
kinase (PERK)), which in unstressed cells, are maintained in an inactive state through 
association with the ER chaperone molecule Grp78.2 When a cell experiences ER stress, 
Grp78 disassociates from each of the three sensor molecules to preferentially bind 
un/misfolded proteins, causing each sensor to activate downstream signaling cascades, 
which ameliorate ER stress via several mechanisms, including selective translation 
inhibition and upregulation of genes that encode enzymes that aid in protein folding, 
maturation, and degradation.3 Involved in this homeostatic/regulatory cascade are two 
target genes Myd116 (growth arrest and DNA damage-inducible protein (Gadd34)) 
and C/EBP homologous protein (CHOP) that are associated with translational recovery 
and apoptosis, respectively.1 Journal of Inflammation Research 2010:3 submit your manuscript | www.dovepress.com
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Tumor cells in vivo are continuously exposed to ER stress 
in their microenvironment through hypoxia, low nutrient 
supply, and low pH. Tumor-intrinsic causes of ER stress 
include oxidative stress, defective glycosylation, and defects 
in calcium homeostasis.4 Evidence suggests that the ability 
to mount the UPR confers upon tumors a growth advan-
tage. Primary human tumor cells of many different origins, 
including breast,5 lung,6 liver,7 colon,8 and prostate,9 have 
been shown to upregulate various elements of the ER stress 
response, including GRP78. In primary human melanoma 
specimens, the level of GRP78 positively correlates with 
tumor progression.10 Conversely, Grp78 hemizygous mice 
crossed with MMTVPyVT heterozygous transgenic mice 
display significantly decreased tumor proliferation, survival, 
and angiogenesis compared to Grp78+/+, PyT mice.11 Addi-
tionally, the inactivation of ER stress signaling by mutations 
of PERK, or by the introduction of a dominant-negative 
PERK, in human colon cancer cells, results in tumors that 
are smaller, grow less rapidly, and display abnormal angio-
genic ability, as compared to their normal counterparts when 
implanted into mice.12,13
Since Virchow’s original suggestion of a link between 
inflammation and tumorigenesis, the idea that inflammation 
in the tumor microenvironment serves as a potent driver of 
tumor progression has been validated by epidemiological and 
molecular evidence. For instance, gastrointestinal carcinogen-
esis is associated with Helicobacter pylori infection, and lung 
cancer correlates with exposure to smoking and asbestos.14,15 
Tumor necrosis factor α (TNF-α) produced by stromal cells 
causes adjacent hepatocytes to undergo transformation into 
malignant cells via nuclear factor kappa-light-chain-enhancer 
of activated B cells (NF-κB) activation16 and, conversely, 
deletion of NF-κB in hepatocytes reduces the incidence of 
liver tumors.17 An additional source of inflammation in the 
tumor microenvironment is infiltrating leukocytes, most 
notably, tumor-associated macrophages.18–20
Recently, ER stress has been linked both to several inflam-
matory diseases and cancer.3,4 Support for the idea that ER 
stress signaling activates an inflammatory program comes 
from evidence demonstrating that signaling through each of 
the three ER stress sensors can activate NF-κB, a master regu-
lator of inflammation.21–23 Previous work from this laboratory 
suggested a link between ER stress and the transcription of 
pro-inflammatory cytokines in vitro. Notably, genome-wide 
array of RNA of murine B lymphoma cells subjected to 
ER stress induced by thapsigargin, a canonical ER stressor, 
showed increased transcription of pro-inflammatory cytokines, 
including interleukin (IL)-6, IL-23p19, and TNF-α.24 Here 
we present evidence that prostate cancer cells undergoing 
ER stress in vitro or in vivo also activate a program of pro-
inflammatory cytokine transcription.
Results and discussion
We used quantitative PCR (qPCR) to analyze the effect of 
thapsigargin on murine transgenic adenocarcinoma of the 
mouse prostate (TRAMP) C1 prostate cancer cells in vitro. 
As expected, cells exposed to thapsigargin (0.3 µM) upregu-
lated the ER stress-responsive genes Grp78, Gadd34, and 
CHOP relative to vehicle-treated cells (Figure 1A). IL-6 and 
IL-23p19 transcript levels also increased 26- and 53-fold, 
respectively, over vehicle-treated cells at the latest time 
point measured (Figure 1B). TNF-α transcript increased 
at 8 hours and declined thereafter. Increased transcription 
of TNF-α was observed but its kinetics in vitro seems to 
follow a pattern inverse to that of Grp78, Gadd34, and 
CHOP (Figure 1, data not shown), suggesting that it may 
be regulated differently than IL-6 and IL-23p19 by UPR 
signaling.
Corroborating these data, we observed an increase in 
intracellular IL-6 protein in TRAMP-C1 cells treated for 
18 hours with thapsigargin (data not shown). Taken together, 
these data suggest that induction of ER stress in prostate can-
cer cells activates a program of pro-inflammatory cytokine 
transcription. It should be pointed out that we observed the 
same phenomenon in diverse tumor cell lines representative 
of melanoma, ovarian cancer, and T- and B-cell lymphoma 
(Gonzalo Almanza, unpublished data).
To corroborate this notion and assess whether a similar 
phenomenon would occur spontaneously in vivo, we uti-
lized a heterotopic tumor transplant model. Briefly, 5 × 106 
TRAMP C1 cells were injected subcutaneously into syn-
geneic C57BL/6 mice, and the tumors excised 7 days later 
to assess the activation of ER stress markers and cytokine 
transcription by qPCR. All but one tumor showed increased 
expression of the ER stress marker Grp78 (data not shown) 
and tumor IL-6, IL-23p19, and TNF-α expression highly cor-
related with Grp78 expression (Figure 2). These data suggest 
that TRAMP C1 tumors undergo spontaneous ER stress in 
vivo and upregulate the transcription of pro-inflammatory 
cytokine genes.
Admittedly, the exact source of these cytokines was not 
determined and is presently unknown. However, since in vitro 
cultured TRAMP C1 cells activate the transcription of IL-6, 
IL-23p19, and TNF-α under ER stress, we argue that ER-
stressed tumor cells are a likely source of these cytokines 
in vivo. A contribution by tumor-associated myeloid cells25 to Journal of Inflammation Research 2010:3 submit your manuscript | www.dovepress.com
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the observed transcriptional activation of IL-6, IL-23p19, and 
TNF-α cannot be formally excluded; however, since the accu-
mulation of myeloid cells in tumors on day 7   post-implantation 
(as was the case in this study) is negligible, if any,26 we maintain 
that the present results can be explained on the basis of tumor 
cells being the source of pro-inflammatory cytokine transcrip-
tion. Future experiments based on cell sorting, coupled with 
phenotype characterization, will be needed to precisely assess 
the role of other cells in tumors in vivo.
The tumorigenic nature of IL-6, IL-23, and TNF-α27–29 
as well as of other molecules released by tumor cells and 
tumor infiltrating immune cells under ER stress,30 makes it 
plausible to suggest that one of the mechanisms by which 
ER stress aids tumor growth is by mediating the release of 
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Figure 1 TRAMP C1 cells activate pro-tumor inflammatory cytokines during ER stress in vitro. TRAMP C1 cells were treated with thapsigargin (Tg) or vehicle control for the 
indicated times and assayed for (a) ER stress marker expression, and (B) pro-inflammatory cytokine transcription, by qPCR. Data columns indicate the mean fold difference 
in transcript level between Tg- and vehicle-treated TRAMP C1 cells. Error bars represent standard error of the mean (sem.) of 2 independent experiments.
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Figure 2 TRAMP C1 cells forming tumors in vivo undergo ER stress and transcriptional activation of pro-inflammatory cytokine genes. TRAMP C1 cells (5 × 106) were 
injected subcutaneously into 12- to 14-week-old male C57BL/6 mice. Seven days after injection, tumors were surgically excised, mechanically disassociated, and assayed for 
Grp78 and pro-inflammatory cytokine transcription, by qPCR. Data points refer to individual tumors, and indicate the fold modulation in transcript level between tumor 
samples and spleen cells from tumor-bearing mice. Correlation was sought using a two-tailed Pearson correlation test. *p = 0.05, **p , 0.05. Journal of Inflammation Research 2010:3 submit your manuscript | www.dovepress.com
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these molecules, which in turn shape the immune landscape 
of the microenvironment to favor tumor progression. It will 
be interesting to see whether tumor cells under ER stress can 
influence surrounding immune cells, such as macrophages. 
In light of the fact that IL-6 and IL-23 have been shown to 
be involved in the differentiation and maintenance of the 
Th17 lineage,31 it is also possible that ER stress mediated 
IL-6 and IL-23 production by tumor cells may enable them 
to modulate CD4+ T-cells in their microenvironment.
Methods
Cells
TRAMP C1 cells were originally obtained through the 
courtesy of Dr Andrew Weinberg (Providence Portland 
Medical Center) and grown in complete RPMI-1640 medium 
supplemented with 10% fetal calf serum. Cells were treated 
with thapsigargin (Alexis Biochemicals) initially dissolved 
in 100% ethanol and diluted in culture medium to a final 
concentration of 0.3 µM, or an equal volume of vehicle only, 
for the indicated times.
Mice and in vivo experiments
C57BL/6 Mice were purchased from Charles River and 
housed at the Moores Cancer Center Animal Facility and 
handled in accordance with University of California, San 
Diego Animal Subjects Program Guidelines (San Diego, 
CA, USA). For tumor inoculation, 5 × 106 TRAMP C1 cells 
were injected subcutaneously into the flank of 12–14 week 
old, male, wild-type C57BL/6 mice. Mice were sacrificed 
7 days after tumor injection when ∼4 mm tumors were 
visible. Tumors were surgically excised and mechanically 
dispersed into cell suspensions. Spleen cells from tumor 
bearing mice C57BL/6 mice were similarly prepared and 
used as controls.
Quantitative RT-PCR
RNA was isolated from cell suspensions using the Nucleopsin 
RNA II Kit (Macherey-Nagel). Genomic DNA was digested 
by on-column treatment with DNase. Concentration and 
purity of RNA was determined by analysis on a NanoDrop 
spectrophotometer (Thermo Scientific). cDNA was obtained 
using the High Capacity cDNA Synthesis kit (Applied Bio-
systems) and quantitative PCR was performed in triplicate 
on an ABI StepOne system using TaqMan reagents. Target 
gene expression was normalized to β-actin, and analyzed 
using the – DDCt relative quantification method. Validated 
FAM-labeled mouse IL-23p19, IL-6, TNF-α, Ddit3 (CHOP), 
Myd116 (Gadd34), Hspa5 (Grp78), and VIC-labeled mouse 
β-actin TaqMan primer/probe sets (Applied Biosystems) 
were used.
Statistical analysis
Statistical analysis was performed using two-tailed Pearson 
correlation test with 95% confidence with the aid of Graph-
Pad Prism software (GraphPad Software, Inc., California, 
USA).
Conclusion
This report shows that murine prostate cancer cells under-
going ER stress initiate a program of pro-inflammatory 
cytokine transcription. TRAMP C1 cells treated in vitro with 
a canonical inducer of ER stress upregulate transcription of 
IL-23p19 and IL-6 concomitantly with upregulation of ER 
stress markers. It also shows that TRAMP C1 tumors in vivo 
spontaneously upregulate markers of ER stress which is 
strongly correlated with the transcription of IL-6, IL-23p19, 
and TNF-α.
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